Search
- Dec 29, 2023
Reviewing the state of biotech with John Maraganore
John Maraganore shares his thoughts about biotech's big achievements in 2023 and what to watch in 2024.
- Dec 28, 2023
As Perlara approaches its 10 yr anniversary, Ethan Perlstein reflects on his entrepreneur's journey and vision for DTC biotech
Ethan Perlstein describes the past and present of his rare diseases-focused company Perlara
- Dec 27, 2023
Xontogeny's Chris Garabedian gives a year-end review and looks ahead to biotech's 2024
Chris Garabedian's thoughts on the IPO market, products vs platforms, and more discipline and prioritization in biotech.
- Dec 26, 2023
Octant Bio's Co-Founder & CEO describes technology advances helping to navigate the biological complexity of multi-modal diseases
Sri Kosuri describes how Octant is using advances in biology, chemistry, multiplexing, and computing to create its platform.
- Dec 19, 2023
Playground Global's $410 million new fund and the firm's philosophy of investing in life sciences
Jory Bell and Nate Chang describe Playground Global's philosophy of investing in life sciences and assisting entrepreneurs.
- Dec 14, 2023
Analyst Thursdays: Evercore ISI Analyst Liisa Bayko takes a deep dive into Vertex's pain data
Liisa Bayko talks about yesterdays pain data and also recent news from Alnylam, Altimmune, Caribou Biosciences, Insmed, and AN2 Therapeutics